More Patients and Medical Articles

Access and Evidence

Bringing innovation to rare disease patients in Europe

Izzy Gladstone, (Feb 17, 2021)

Johanna Friedl-Naderer, President, Europe, Canada & Partner Markets, Biogen on how collaboration between governments and industry can lead to better patient outcomes.
Access and Evidence

#Icare4Rare campaign launches to raise awareness ahead of Rare Disease Week 2021

Izzy Gladstone, (Feb 11, 2021)

To help raise awareness of rare disease, Reuters Events, Biogen and EU40 have collaborated to launch the #Icare4rare campaign to give prominence to Rare Disease Week 2021
Patients and Medical

Better research through patient insights

Andrew Stone, (Jan 26, 2021)

AstraZeneca’s innovations in chronic kidney disease are pointing the way to new ways of involving patients and RWE to drive new insights and better outcomes
Patients and Medical

Building a health equity culture

Andrew Stone, (Nov 17, 2020)

Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts
Patients and Medical

Digital companions: helping improve patient treatment journeys

Katie Osborne, (Oct 23, 2020)

The virtual health explosion isn't going away. This just at the start of an era of digital enhancement
Patients and Medical

Racially diverse clinical trials: A new patient-led legacy takes root

Andrew Stone, (Oct 15, 2020)

Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities
Patients and Medical

Patient engagement: Breaking through in digital

Andrew Stone, (Oct 14, 2020)

The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential
Patients and Medical

Amplifying the patient voice in rare disease access

Elly Aylwin-Foster, (Oct 2, 2020)

Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom
Patients and Medical

From complexity to clarity in cell and gene therapy

Andrew Stone, (Sep 16, 2020)

Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Patients and Medical

The future of Medical Affairs: A virtual Q&A with Charlotte Kremer

Andrew Stone, (Sep 10, 2020)

The Astellas head of medical affairs follows up with answers to questions during her virtual keynote earlier this year

Pages